59 related articles for article (PubMed ID: 27966559)
1. Corrigendum to "Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo".
Mol Ther; 2016 Dec; 24(12):2131-2132. PubMed ID: 27966559
[No Abstract] [Full Text] [Related]
2. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.
Yoon S; Huang KW; Reebye V; Mintz P; Tien YW; Lai HS; Sætrom P; Reccia I; Swiderski P; Armstrong B; Jozwiak A; Spalding D; Jiao L; Habib N; Rossi JJ
Mol Ther; 2016 Jun; 24(6):1106-1116. PubMed ID: 26983359
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.
Yoon S; Huang KW; Andrikakou P; Vasconcelos D; Swiderski P; Reebye V; Sodergren M; Habib N; Rossi JJ
Mol Ther Nucleic Acids; 2019 Dec; 18():142-154. PubMed ID: 31546149
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.
Yoon S; Rossi JJ
Adv Exp Med Biol; 2017; 983():173-188. PubMed ID: 28639199
[TBL] [Abstract][Full Text] [Related]
5. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
6. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
[TBL] [Abstract][Full Text] [Related]
7. Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma.
Champanhac C; Teng IT; Cansiz S; Zhang L; Wu X; Zhoa Z; Fu T; Tan W
Sci Rep; 2015 Nov; 5():16788. PubMed ID: 26603187
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of VEZT by small activating RNA inhibits the proliferation, invasion and migration of gastric cancer cells.
Xie D; Shang L; Peng L; Li L
Biochem Biophys Res Commun; 2017 Jan; 482(4):542-548. PubMed ID: 27856244
[TBL] [Abstract][Full Text] [Related]
9. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
[TBL] [Abstract][Full Text] [Related]
10. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition.
Wu X; Zhao Z; Bai H; Fu T; Yang C; Hu X; Liu Q; Champanhac C; Teng IT; Ye M; Tan W
Theranostics; 2015; 5(9):985-94. PubMed ID: 26155314
[TBL] [Abstract][Full Text] [Related]
11. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
12. saRNA guided iNOS up-regulation improves erectile function of diabetic rats.
Wang T; Li M; Yuan H; Zhan Y; Xu H; Wang S; Yang W; Liu J; Ye Z; Li LC
J Urol; 2013 Aug; 190(2):790-8. PubMed ID: 23523927
[TBL] [Abstract][Full Text] [Related]
13. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
[TBL] [Abstract][Full Text] [Related]
14. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
15. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
16. Suppression of proline-directed protein kinase F(A) inhibits the malignant growth of human pancreatic ductal adenocarcinoma.
Fu HH; Yang SD
Anticancer Res; 2004; 24(3a):1489-94. PubMed ID: 15274314
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
18. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
20. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats].
Liang S; Yang ZL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]